What is HC Wainwright’s Forecast for Senestech Q3 Earnings?

Senestech, Inc. (NASDAQ:SNES) – Research analysts at HC Wainwright boosted their Q3 2026 earnings per share (EPS) estimates for shares of Senestech in a research report issued on Tuesday, August 11th. HC Wainwright analyst A. Dayal now forecasts that the company will earn ($0.31) per share for the quarter, up from their prior forecast of ($0.41). The consensus estimate for Senestech’s current full-year earnings is ($1.57) per share. HC Wainwright also issued estimates for Senestech’s Q4 2026 earnings at ($0.32) EPS, FY2026 earnings at ($1.28) EPS, FY2027 earnings at ($1.15) EPS, FY2028 earnings at ($0.38) EPS and FY2029 earnings at $0.22 EPS.

Senestech (NASDAQ:SNES) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.02. The business had revenue of $0.77 million for the quarter, compared to analysts’ expectations of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%.

Separately, Weiss Ratings lowered Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Senestech Stock Performance

Senestech stock opened at $1.26 on Thursday. The stock has a fifty day moving average price of $1.48 and a 200 day moving average price of $1.70. Senestech has a 52 week low of $1.15 and a 52 week high of $5.35. The firm has a market capitalization of $6.86 million, a P/E ratio of -0.92 and a beta of 0.28. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02.

Insider Transactions at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management acquired 35,000 shares of the firm’s stock in a transaction on Monday, July 20th. The stock was bought at an average cost of $1.47 per share, for a total transaction of $51,450.00. Following the completion of the purchase, the insider directly owned 1,057,824 shares in the company, valued at $1,555,001.28. This represents a 3.42% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have purchased 148,263 shares of company stock worth $223,539 in the last ninety days. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Senestech

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC purchased a new stake in Senestech during the 2nd quarter worth $59,000. Jane Street Group LLC purchased a new position in Senestech in the fourth quarter valued at about $32,000. Diversify Advisory Services LLC purchased a new position in Senestech in the fourth quarter valued at about $34,000. Diversify Wealth Management LLC acquired a new position in shares of Senestech during the first quarter worth about $31,000. Finally, XTX Topco Ltd acquired a new position in shares of Senestech during the fourth quarter worth about $54,000. Institutional investors and hedge funds own 5.19% of the company’s stock.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.